| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Stoke Therapeutics, Inc. (STOK) has 15 insiders with recent SEC Form 4 filings, including 2 buys and 21 sells. STOK is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 3.91M | $123.83M | - | |
| CEO | 380.0K | $12.05M | - | |
| Dir | 283.3K | $8.98M | - | |
| Other | 118.7K | $3.76M | - | |
| Dir | 110.9K | $3.51M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 25, 2020 | Kaye Edward M. Md47 | CEO | Sell | 12,848 | $50.00 | $642,400.00 | -25.7% | |
| Nov 24, 2020 | Harrison Seth Loring | Director, 10% Owner | Buy | 375,000 | $39.00 | $14,625,000.00 | +2.2% | |
| Nov 24, 2020 | Apple Tree Partners Iv, L.P. | 10% Owner | Buy | 375,000 | $39.00 | $14,625,000.00 | +2.2% | |
| Nov 23, 2020 | Tzianabos Arthur74 | Director | Sale+OE | 20,000 | $46.03 | $920,565.67 | -48.3% | |
| Nov 10, 2020 | Nash Huw M.81 | COO &Cbo | Sale+OE | 50,000 | $45.00 | $2,250,000.00 | -100% | |
| Nov 4, 2020 | Tulipano Stephen J | CFO | Sale+OE | 70,000 | $39.00 | $2,729,938.53 | -63.1% | |
| Nov 2, 2020 | Nash Huw M.81 | COO &Cbo | Sale+OE | 5,700 | $37.21 | $212,109.89 | -69.2% | |
| Oct 19, 2020 | Liau Gene | EVP Research &Preclinical Dev | Sale+OE | 37,851 | $38.16 | $1,444,205.77 | -44.2% | |
| Oct 13, 2020 | Liau Gene | EVP Research &Preclinical Dev | Sale+OE | 1,649 | $40.00 | $65,960.00 | -10.9% | |
| Oct 1, 2020 | Nash Huw M.81 | COO &Cbo | Sale+OE | 5,700 | $34.54 | $196,900.52 | -71.3% |